Pulmagen Therapeutics (Synergy) Limited;AstraZeneca AB
发明人:
Mather, Andrew,Ford, Rhonan,Wiley, Katherine,Mete, Antonio,Bull, Richard, James
申请号：
AU2009247021
公开号：
AU2009247021B2
申请日:
2009.05.12
申请国别(地区):
AU
年份:
2012
代理人:
摘要：
The invention provides a pharmaceutical product, kit or composition comprising a first active ingredient which is a selected muscarinic receptor antagonist, and a second active ingredient which is a β-adrenoceptor agonist, of use in the treatment of respiratory diseases such as chronic obstructive pulmonary disease and asthma.
